Protein stability of p53 targets determines their temporal expression dynamics in response to p53 pulsing.


Journal

The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 12 03 2018
revised: 20 09 2018
accepted: 12 11 2018
pubmed: 13 2 2019
medline: 14 4 2020
entrez: 13 2 2019
Statut: ppublish

Résumé

In response to DNA damage, the transcription factor p53 accumulates in a series of pulses. While p53 dynamics play a critical role in regulating stress responses, how p53 pulsing affects target protein expression is not well understood. Recently, we showed that p53 pulses generate diversity in target mRNA expression dynamics; however, given that mRNA and protein expression are not necessarily well correlated, it remains to be determined how p53 pulses impact target protein expression. Using computational and experimental approaches, we show that target protein decay rates filter p53 pulses: Distinct target protein expression dynamics are generated depending on the relationship between p53 pulse frequency and target mRNA and protein stability. Furthermore, by mutating the targets MDM2 and PUMA to alter their stabilities, we show that downstream pathways are sensitive to target protein decay rates. This study delineates the mechanisms by which p53 dynamics play a crucial role in orchestrating the timing of events in the DNA damage response network.

Identifiants

pubmed: 30745421
pii: jcb.201803063
doi: 10.1083/jcb.201803063
pmc: PMC6446860
doi:

Substances chimiques

Apoptosis Regulatory Proteins 0
BBC3 protein, human 0
Proto-Oncogene Proteins 0
RNA, Messenger 0
TP53 protein, human 0
Tumor Suppressor Protein p53 0
Zinostatin 9014-02-2
MDM2 protein, human EC 2.3.2.27
Proto-Oncogene Proteins c-mdm2 EC 2.3.2.27

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1282-1297

Subventions

Organisme : Intramural NIH HHS
ID : ZIA BC011382
Pays : United States

Informations de copyright

This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

Références

J Biol Chem. 2000 Apr 21;275(16):12185-93
pubmed: 10766854
Nat Genet. 2001 Mar;27(3):247-54
pubmed: 11242102
Genes Dev. 2001 May 1;15(9):1067-77
pubmed: 11331603
Genome Res. 2003 Sep;13(9):2129-41
pubmed: 12952881
Nature. 1992 Dec 10;360(6404):597-9
pubmed: 1334232
Nat Genet. 2004 Feb;36(2):147-50
pubmed: 14730303
EMBO J. 2004 Apr 7;23(7):1547-56
pubmed: 15029243
Cancer Cell. 2006 May;9(5):351-65
pubmed: 16697956
Mol Syst Biol. 2006;2:2006.0033
pubmed: 16773083
Cell. 2006 Jul 14;126(1):107-20
pubmed: 16839880
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13004-9
pubmed: 16916930
Cell Cycle. 2007 Jan 1;6(1):85-94
pubmed: 17245126
Cancer Res. 2007 Apr 1;67(7):3043-53
pubmed: 17409411
Cell. 2007 Aug 24;130(4):597-600
pubmed: 17719538
Hum Mutat. 2008 Feb;29(2):332
pubmed: 18205192
EMBO J. 2008 Apr 9;27(7):1039-48
pubmed: 18337750
Mol Cell. 2008 May 9;30(3):277-89
pubmed: 18471974
Science. 2008 Nov 7;322(5903):918-23
pubmed: 18988847
Nat Immunol. 2009 Mar;10(3):281-8
pubmed: 19198593
BMC Bioinformatics. 2009 Jun 22;10:190
pubmed: 19545411
Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12245-50
pubmed: 19617533
Mol Biosyst. 2009 Dec;5(12):1512-26
pubmed: 20023718
Cell Cycle. 2010 Jan 15;9(2):389-97
pubmed: 20046100
BMC Genomics. 2010 Apr 21;11:259
pubmed: 20409322
Nature. 2010 Jul 8;466(7303):267-71
pubmed: 20581820
Genes Dev. 2011 Mar 1;25(5):409-33
pubmed: 21363960
Mol Syst Biol. 2011 May 10;7:488
pubmed: 21556066
Nature. 2011 May 19;473(7347):337-42
pubmed: 21593866
Mol Cell Proteomics. 2012 Mar;11(3):M111.011429
pubmed: 21937730
J Proteome Res. 2011 Dec 2;10(12):5275-84
pubmed: 22050367
Cell Death Differ. 2012 Sep;19(9):1424-34
pubmed: 22361683
Nat Rev Genet. 2012 Mar 13;13(4):227-32
pubmed: 22411467
Science. 2012 Jun 15;336(6087):1440-4
pubmed: 22700930
J Cell Sci. 2012 Nov 15;125(Pt 22):5280-7
pubmed: 22899723
Mol Cell. 2013 Jan 24;49(2):249-61
pubmed: 23219535
BMC Biol. 2013 Jun 21;11:73
pubmed: 23800173
Cell Stem Cell. 2013 Oct 3;13(4):483-91
pubmed: 23954752
J Am Soc Nephrol. 2013 Nov;24(11):1793-805
pubmed: 24029424
BMC Biol. 2013 Nov 19;11:114
pubmed: 24252182
Science. 2013 Dec 6;342(6163):1193-200
pubmed: 24311681
Science. 2016 Mar 11;351(6278):1204-8
pubmed: 26965628
Cell. 2016 Apr 21;165(3):631-42
pubmed: 27062928
Cell Syst. 2016 Apr 27;2(4):272-82
pubmed: 27135539
Sci Signal. 2017 Apr 25;10(476):
pubmed: 28442631
Nat Struct Mol Biol. 2017 Oct;24(10):840-847
pubmed: 28825732
Carcinogenesis. 1983;4(7):917-21
pubmed: 6223717

Auteurs

Ryan L Hanson (RL)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Joshua R Porter (JR)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Eric Batchelor (E)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD batchelore@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH